The global Epigenome Analysis market is projected to reach US$ 1537.8 million in 2029, increasing from US$ 829 million in 2022, with the CAGR of 9.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Epigenome Analysis market research.
Epigenome analysis has garnered increasing research interest across various fields of biology and medicine. The exploration of epigenetic mechanisms in gene regulation and disease development has driven the demand for advanced epigenome analysis technologies and tools. Technological advancements in epigenome analysis, such as next-generation sequencing (NGS) and high-throughput methods, have significantly improved the efficiency and accuracy of epigenetic studies. These advancements have facilitated large-scale epigenome mapping and analysis. Epigenome analysis has found extensive applications in disease research, including cancer, neurological disorders, and autoimmune diseases. Understanding epigenetic modifications can provide valuable insights into disease mechanisms and potential therapeutic targets.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epigenome Analysis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Cellcentric
Syndax
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Enzo Life Sciences
EpiGentek Group
BioVision
Promega Corporation
GeneTex
Pacific Biosciences of California
Segment by Type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segment by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Epigenome Analysis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenome Analysis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 DNA Methylation Analysis
1.2.3 Analysis of DNA Interactions
1.2.4 Chromatin Accessibility
1.2.5 Conformation Assays
1.3 Market by Application
1.3.1 Global Epigenome Analysis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenome Analysis Market Perspective (2018-2029)
2.2 Epigenome Analysis Growth Trends by Region
2.2.1 Global Epigenome Analysis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Epigenome Analysis Historic Market Size by Region (2018-2023)
2.2.3 Epigenome Analysis Forecasted Market Size by Region (2024-2029)
2.3 Epigenome Analysis Market Dynamics
2.3.1 Epigenome Analysis Industry Trends
2.3.2 Epigenome Analysis Market Drivers
2.3.3 Epigenome Analysis Market Challenges
2.3.4 Epigenome Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenome Analysis Players by Revenue
3.1.1 Global Top Epigenome Analysis Players by Revenue (2018-2023)
3.1.2 Global Epigenome Analysis Revenue Market Share by Players (2018-2023)
3.2 Global Epigenome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Epigenome Analysis Revenue
3.4 Global Epigenome Analysis Market Concentration Ratio
3.4.1 Global Epigenome Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenome Analysis Revenue in 2022
3.5 Epigenome Analysis Key Players Head office and Area Served
3.6 Key Players Epigenome Analysis Product Solution and Service
3.7 Date of Enter into Epigenome Analysis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenome Analysis Breakdown Data by Type
4.1 Global Epigenome Analysis Historic Market Size by Type (2018-2023)
4.2 Global Epigenome Analysis Forecasted Market Size by Type (2024-2029)
5 Epigenome Analysis Breakdown Data by Application
5.1 Global Epigenome Analysis Historic Market Size by Application (2018-2023)
5.2 Global Epigenome Analysis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Epigenome Analysis Market Size (2018-2029)
6.2 North America Epigenome Analysis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Epigenome Analysis Market Size by Country (2018-2023)
6.4 North America Epigenome Analysis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Epigenome Analysis Market Size (2018-2029)
7.2 Europe Epigenome Analysis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Epigenome Analysis Market Size by Country (2018-2023)
7.4 Europe Epigenome Analysis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epigenome Analysis Market Size (2018-2029)
8.2 Asia-Pacific Epigenome Analysis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Epigenome Analysis Market Size by Region (2018-2023)
8.4 Asia-Pacific Epigenome Analysis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Epigenome Analysis Market Size (2018-2029)
9.2 Latin America Epigenome Analysis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Epigenome Analysis Market Size by Country (2018-2023)
9.4 Latin America Epigenome Analysis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenome Analysis Market Size (2018-2029)
10.2 Middle East & Africa Epigenome Analysis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Epigenome Analysis Market Size by Country (2018-2023)
10.4 Middle East & Africa Epigenome Analysis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Epigenome Analysis Introduction
11.1.4 Illumina Revenue in Epigenome Analysis Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Epigenome Analysis Introduction
11.2.4 Merck Revenue in Epigenome Analysis Business (2018-2023)
11.2.5 Merck Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Epigenome Analysis Introduction
11.3.4 QIAGEN Revenue in Epigenome Analysis Business (2018-2023)
11.3.5 QIAGEN Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Epigenome Analysis Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Epigenome Analysis Business (2018-2023)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Eisai
11.5.1 Eisai Company Detail
11.5.2 Eisai Business Overview
11.5.3 Eisai Epigenome Analysis Introduction
11.5.4 Eisai Revenue in Epigenome Analysis Business (2018-2023)
11.5.5 Eisai Recent Development
11.6 Abcam
11.6.1 Abcam Company Detail
11.6.2 Abcam Business Overview
11.6.3 Abcam Epigenome Analysis Introduction
11.6.4 Abcam Revenue in Epigenome Analysis Business (2018-2023)
11.6.5 Abcam Recent Development
11.7 Diagenode
11.7.1 Diagenode Company Detail
11.7.2 Diagenode Business Overview
11.7.3 Diagenode Epigenome Analysis Introduction
11.7.4 Diagenode Revenue in Epigenome Analysis Business (2018-2023)
11.7.5 Diagenode Recent Development
11.8 Active Motif
11.8.1 Active Motif Company Detail
11.8.2 Active Motif Business Overview
11.8.3 Active Motif Epigenome Analysis Introduction
11.8.4 Active Motif Revenue in Epigenome Analysis Business (2018-2023)
11.8.5 Active Motif Recent Development
11.9 Zymo Research Corporation
11.9.1 Zymo Research Corporation Company Detail
11.9.2 Zymo Research Corporation Business Overview
11.9.3 Zymo Research Corporation Epigenome Analysis Introduction
11.9.4 Zymo Research Corporation Revenue in Epigenome Analysis Business (2018-2023)
11.9.5 Zymo Research Corporation Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Epigenome Analysis Introduction
11.10.4 Thermo Fisher Scientific Revenue in Epigenome Analysis Business (2018-2023)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Cellcentric
11.11.1 Cellcentric Company Detail
11.11.2 Cellcentric Business Overview
11.11.3 Cellcentric Epigenome Analysis Introduction
11.11.4 Cellcentric Revenue in Epigenome Analysis Business (2018-2023)
11.11.5 Cellcentric Recent Development
11.12 Syndax
11.12.1 Syndax Company Detail
11.12.2 Syndax Business Overview
11.12.3 Syndax Epigenome Analysis Introduction
11.12.4 Syndax Revenue in Epigenome Analysis Business (2018-2023)
11.12.5 Syndax Recent Development
11.13 New England Biolabs
11.13.1 New England Biolabs Company Detail
11.13.2 New England Biolabs Business Overview
11.13.3 New England Biolabs Epigenome Analysis Introduction
11.13.4 New England Biolabs Revenue in Epigenome Analysis Business (2018-2023)
11.13.5 New England Biolabs Recent Development
11.14 Epizyme
11.14.1 Epizyme Company Detail
11.14.2 Epizyme Business Overview
11.14.3 Epizyme Epigenome Analysis Introduction
11.14.4 Epizyme Revenue in Epigenome Analysis Business (2018-2023)
11.14.5 Epizyme Recent Development
11.15 Domainex
11.15.1 Domainex Company Detail
11.15.2 Domainex Business Overview
11.15.3 Domainex Epigenome Analysis Introduction
11.15.4 Domainex Revenue in Epigenome Analysis Business (2018-2023)
11.15.5 Domainex Recent Development
11.16 Agilent Technologies
11.16.1 Agilent Technologies Company Detail
11.16.2 Agilent Technologies Business Overview
11.16.3 Agilent Technologies Epigenome Analysis Introduction
11.16.4 Agilent Technologies Revenue in Epigenome Analysis Business (2018-2023)
11.16.5 Agilent Technologies Recent Development
11.17 AsisChem
11.17.1 AsisChem Company Detail
11.17.2 AsisChem Business Overview
11.17.3 AsisChem Epigenome Analysis Introduction
11.17.4 AsisChem Revenue in Epigenome Analysis Business (2018-2023)
11.17.5 AsisChem Recent Development
11.18 Enzo Life Sciences
11.18.1 Enzo Life Sciences Company Detail
11.18.2 Enzo Life Sciences Business Overview
11.18.3 Enzo Life Sciences Epigenome Analysis Introduction
11.18.4 Enzo Life Sciences Revenue in Epigenome Analysis Business (2018-2023)
11.18.5 Enzo Life Sciences Recent Development
11.19 EpiGentek Group
11.19.1 EpiGentek Group Company Detail
11.19.2 EpiGentek Group Business Overview
11.19.3 EpiGentek Group Epigenome Analysis Introduction
11.19.4 EpiGentek Group Revenue in Epigenome Analysis Business (2018-2023)
11.19.5 EpiGentek Group Recent Development
11.20 BioVision
11.20.1 BioVision Company Detail
11.20.2 BioVision Business Overview
11.20.3 BioVision Epigenome Analysis Introduction
11.20.4 BioVision Revenue in Epigenome Analysis Business (2018-2023)
11.20.5 BioVision Recent Development
11.21 Promega Corporation
11.21.1 Promega Corporation Company Detail
11.21.2 Promega Corporation Business Overview
11.21.3 Promega Corporation Epigenome Analysis Introduction
11.21.4 Promega Corporation Revenue in Epigenome Analysis Business (2018-2023)
11.21.5 Promega Corporation Recent Development
11.22 GeneTex
11.22.1 GeneTex Company Detail
11.22.2 GeneTex Business Overview
11.22.3 GeneTex Epigenome Analysis Introduction
11.22.4 GeneTex Revenue in Epigenome Analysis Business (2018-2023)
11.22.5 GeneTex Recent Development
11.23 Pacific Biosciences of California
11.23.1 Pacific Biosciences of California Company Detail
11.23.2 Pacific Biosciences of California Business Overview
11.23.3 Pacific Biosciences of California Epigenome Analysis Introduction
11.23.4 Pacific Biosciences of California Revenue in Epigenome Analysis Business (2018-2023)
11.23.5 Pacific Biosciences of California Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Cellcentric
Syndax
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Enzo Life Sciences
EpiGentek Group
BioVision
Promega Corporation
GeneTex
Pacific Biosciences of California
*If Applicable.